Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, M...( _new http://www.b ...),Health
Navigation Links
Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009
Date:4/30/2009
="_new">http://www.bionovo.com.
'/>"/>
| SOURCE Bionovo, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
2. JAG Media Holdings, Inc. Announces Update of the Status of its Proposed Acquisition of CardioGenics Inc.
3. West Announces First Quarter 2009 Results
4. Nuvo announces 2009 first quarter financial results
5. IRIDEX Announces Shipment of New IQ 577(TM) Laser Systems
6. Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call
7. ThermoGenesis Corp. to Announce Third Quarter Fiscal 2009 Results on May 6, 2009
8. Management Health Solutions, Inc. Announces Release v1.0 to Clinical Inventory Valuation Solution
9. Medeguide Announces Online Marketing Partnership with Admax Plus to Promote Doctors and Treatment Packages Online
10. Nektar to Announce Financial Results for the First Quarter of 2009 on Wednesday, May 6, 2009, After Close of U.S.-Based Financial Markets
11. Stryker Announces Election of New Director
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award 2Health News:Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 3Health News:Sticks and stones break bones, but this UH study may prevent it 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 3
[0] Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award[0] Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010[0] IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care[0] Sticks and stones break bones, but this UH study may prevent it[0] Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries
Other Medicine News:Health News:National Heart Lung and Blood Institute creates national network to study cardiovascular disease 2Health News:Bond Laboratories Selects Wasserman Media Group 2Health News:Bond Laboratories Selects Wasserman Media Group 3Health News:NanoLogix Inc. Files Multiple International Patent Applications for BioNanoChannel(TM) and Hydrogen Bioreactor Technology 2Health News:Frederick R. Appelbaum, M.D. and Ross C. Donehower, M.D. Join Scientific Advisory Board of Celator(R) Pharmaceuticals 2Health News:Lack of Sleep Tied to Weight Gain in New Moms 2
National Heart Lung and Blood Institute creates national network to study cardiovascular diseaseBond Laboratories Selects Wasserman Media GroupNanoLogix Inc. Files Multiple International Patent Applications for BioNanoChannel(TM) and Hydrogen Bioreactor TechnologyFrederick R. Appelbaum, M.D. and Ross C. Donehower, M.D. Join Scientific Advisory Board of Celator(R) PharmaceuticalsLack of Sleep Tied to Weight Gain in New MomsDr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
Breaking Medicine Technology:ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3The American Society of Transplantation Announces Dr Joren C Madsen as President 49219 1The American Society of Transplantation Announces Dr Joren C Madsen as President 49219 2BenefitMall Hosts New World of Healthcare Forum to Empower Partners to Find Solutions for Volatile Healthcare Industry 49218 1BenefitMall Hosts New World of Healthcare Forum to Empower Partners to Find Solutions for Volatile Healthcare Industry 49218 2BenefitMall Hosts New World of Healthcare Forum to Empower Partners to Find Solutions for Volatile Healthcare Industry 49218 3John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 1John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 2John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 3John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 4
[0] Solos Endoscopy, Inc. Reports Sales Increase for October 2009 and November 2009 as Compared to Same Two Months in 2008[0] ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference[0] Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Other Medicine Technology:Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 2Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 3Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 4Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 5Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 6Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 7Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 8Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 2Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |